Kura Oncology Announces Pricing of $300 Million Public Offering of Common Stock

by NASDAQ Market News December 9, 2020

NASDAQ Market News
Click here to email author

HOOKIPA Pharma Announces Pricing of Public Offering of Common Stock and Preferred Stock

Sorrento Receives Licensure From the State of California for Clinical Testing Laboratory (CLIA) Allowing for Clinical Sample Testing

Ads